Anders Hultman

(Mr. Anders Hultman)

Currently holds positions in AroCell AB (publ) and Calliditas Therapeutics AB

Positions
Position Company Period
Chief Financial Officer AroCell AB (publ) Dec. 1, 2018 -
Chief Financial Officer Calliditas Therapeutics AB None -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-05-11 2022-05-10
B Purchase
90,000
0.45
40,500 SEK 		90,000 0.45 40,500 SEK
2022-05-09 2022-05-09
B Purchase
460,000
0.48
220,800 SEK 		460,000 0.48 220,800 SEK
2022-05-03 2022-05-03
B Purchase
25,000
0.50
12,425 SEK 		25,000 0.50 12,425 SEK
2021-01-19 2021-01-19
B Purchase
20,000
2.67
53,312 SEK 		20,000 2.67 53,312 SEK
2019-12-06 2019-12-04
B Purchase
60,000
1.50
90,000 SEK 		60,000 1.50 90,000 SEK
2019-11-27 2019-11-26
B Purchase
60,000
0.01
522 SEK 		60,000 0.01 522 SEK
2019-11-26 2019-11-26
B Purchase
60,000
0.01
522 SEK 		60,000 0.01 522 SEK
2018-12-05 2018-12-05
B Purchase
7,831
2.24
17,541 SEK 		7,831 2.24 17,541 SEK
2018-11-28 2018-11-28
B Purchase
10,000
2.51
25,100 SEK 		10,000 2.51 25,100 SEK
2018-11-21 2018-11-21
B Purchase
10,000
2.50
25,000 SEK 		10,000 2.50 25,000 SEK
2018-11-15 2018-11-15
B Purchase
7,400
2.73
20,202 SEK 		7,400 2.73 20,202 SEK
2018-11-14 2018-11-14
B Purchase
20,000
3.10
62,000 SEK 		20,000 3.10 62,000 SEK